J.M. Ruiz Caro Larrea, S. Simpson, G.-Y. Wong, D. Ah-kine, A. Gibson, T.M. Lupión Durán
{"title":"Manejo de tumores perioculares mediante derivación a cirugía de Mohs y sus características clínico-histológicas","authors":"J.M. Ruiz Caro Larrea, S. Simpson, G.-Y. Wong, D. Ah-kine, A. Gibson, T.M. Lupión Durán","doi":"10.1016/j.oftal.2024.07.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Antecedents and Objectives</h3><div>The aim of our study was to showcase that micrographic Mohs surgery (MMS) can be used efficiently even if unavailable (James Cook Hospital) in the management of periocular tumors through MMS via referral (Royal Victoria Infirmary Hospital), and describe our patients’ clinical and histological features.</div></div><div><h3>Materials and methods</h3><div>We conducted a retrospective, longitudinal and descriptive study with 58 patients. We categorized our patients in 3 groups; pre-COVID-19: patients from January 2019 through January 28<sup>th</sup> 2020, COVID-19: patients from January 29<sup>th</sup> 2020 through July 2021 and late COVID-19: patients from August 2021 through July 24<sup>th</sup> 2023.</div></div><div><h3>Results</h3><div>No differences across groups were reported; the date of first consultation (DFC) and MMS (<em>P</em> <!-->=<!--> <!-->.06), the date of the referral request (DRR) and MMS (p<!--> <!-->=<!--> <!-->0,054), the MMS date to reconstruction (<em>P</em> <!-->=<!--> <!-->.19), and the time of lesion onset (<em>P</em> <!-->=<!--> <!-->.054). The type of reconstruction was not impacted by the number of days between the clinic date and reconstruction (<em>P</em> <!-->=<!--> <!-->.60), the DFC and MMS (<em>P</em> <!-->=<!--> <!-->.60), and the DRR and MMS (<em>P</em> <!-->=<!--> <!-->.27). Nearly 16% of patients were discharged during their first postoperative visit.</div></div><div><h3>Conclusion</h3><div>The combined management of periocular tumors across 2 hospitals proved effective, even though the COVID-19 pandemic.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 3","pages":"Pages 119-124"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivos De La Sociedad Espanola De Oftalmologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S036566912400128X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Antecedents and Objectives
The aim of our study was to showcase that micrographic Mohs surgery (MMS) can be used efficiently even if unavailable (James Cook Hospital) in the management of periocular tumors through MMS via referral (Royal Victoria Infirmary Hospital), and describe our patients’ clinical and histological features.
Materials and methods
We conducted a retrospective, longitudinal and descriptive study with 58 patients. We categorized our patients in 3 groups; pre-COVID-19: patients from January 2019 through January 28th 2020, COVID-19: patients from January 29th 2020 through July 2021 and late COVID-19: patients from August 2021 through July 24th 2023.
Results
No differences across groups were reported; the date of first consultation (DFC) and MMS (P = .06), the date of the referral request (DRR) and MMS (p = 0,054), the MMS date to reconstruction (P = .19), and the time of lesion onset (P = .054). The type of reconstruction was not impacted by the number of days between the clinic date and reconstruction (P = .60), the DFC and MMS (P = .60), and the DRR and MMS (P = .27). Nearly 16% of patients were discharged during their first postoperative visit.
Conclusion
The combined management of periocular tumors across 2 hospitals proved effective, even though the COVID-19 pandemic.
期刊介绍:
La revista Archivos de la Sociedad Española de Oftalmología, editada mensualmente por la propia Sociedad, tiene como objetivo publicar trabajos de investigación básica y clínica como artículos originales; casos clínicos, innovaciones técnicas y correlaciones clinicopatológicas en forma de comunicaciones cortas; editoriales; revisiones; cartas al editor; comentarios de libros; información de eventos; noticias personales y anuncios comerciales, así como trabajos de temas históricos y motivos inconográficos relacionados con la Oftalmología. El título abreviado es Arch Soc Esp Oftalmol, y debe ser utilizado en bibliografías, notas a pie de página y referencias bibliográficas.